The International Master Course on Aging Science (IMCAS) World Congress 2025 will take place from 30 January – 1 February in Paris, where industry experts will share the latest scientific research and technology innovation in dermatology, cosmeceuticals, ageing science, regenerative medicine and plastic surgery.
This year organisers expect more than 18,700 participants. The event is set to open with a conference that will include topics such as key industry trends, exosomes, AI for skin cancer diagnosis, biohacking and regenerative medicine, and global trends on GLP-1.
There will also be talks from IMCAS’ Scientific Directors Hugues Cartier and Sebastien Garson.
Galderma to present new data
Some of the beauty industry’s biggest players will be launching innovations at the event.
Swiss company Galderma is set to present the latest updates from its aesthetics portfolio and will share 10 research e-posters for its injectable aesthetic products, including Relfydess (RelabotulinumtoxinA), Sculptra and Restylane.
Alongside its community partners, Galderma will also host three symposia, a Masterclass, five Meet the Expert sessions, and an interactive booth focused on its Relfydess product.
Galderma’s global head of R&D Baldo Scassellati Sforzolini MD PhD said: “With such an extensive presence at the IMCAS congress this year, we have another opportunity not only to share the latest advancements from our broad and innovative injectable aesthetics portfolio, but also to connect with the community in a meaningful way, through information sharing and insights gathering.”
The new data will include results from a study investigating the long-term aesthetic improvement and subject satisfaction over 12 months following a single dose of Relfydess in patients with moderate-to-severe frown lines.
This study reinforces previously announced data, demonstrating that up to 39% of patients see effects from day one and up to 75% of patients maintain improvements for six months for frown lines and crow’s feet when treated with Relfydess.
Galderma will also present the latest data on Sculptra, the “first proven regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA™) formulation.”
New data reinforces its regenerative properties and effects across all three skin layers, underscoring its key role in the regenerative aesthetics field, including its benefit in comparison to other products.
Studies suggested Sculptra stimulated the key components of the skin, including collagen, elastin and adipose tissue, and reinforced its safety profile.
Another comparative study found synergistic effects for the midface when pairing Sculptra with Alastin®, with an improvement in aging skin and patient experience when using both.
L’Oréal to focus on longevity science
The French multinational L’Oréal will also be present at the global congress.
Speakers will include: Luc Aguilar from L’Oréal’s R&D division who will discuss ‘the science of longevity, while Frederic Flament, also from its R&D division, will explore skin longevity (including atlases, AI-driven diagnostic, invisible biomarkers analysis).
Guests will also hear from Natalia Kovylkina of Vichy, who is a collagen specialist, and Annie Black from the Lancôme brand, who will speak about boosting mitochondrial function for skin longevity
Julie Faitg from biotech firm Time Line, which L’Oréal invested in one year ago, will also join the line up to discuss targeting mitochondrial health to boost skin healthspan and longevity with ‘mitopure’®.
Unilever to talk about exosomes and skin microbiome
UK multinational Unilever is also set to present a symposium at the congress, which will cover hot topics in the skin care category from exosomes to microbiome.
